Target Price | $74.67 |
Price | $58.03 |
Potential |
28.67%
register free of charge
|
Number of Estimates | 18 |
18 Analysts have issued a price target Doximity 2026 .
The average Doximity target price is $74.67.
This is
28.67%
register free of charge
$90.00
55.09%
register free of charge
$55.00
5.22%
register free of charge
|
|
A rating was issued by 20 analysts: 8 Analysts recommend Doximity to buy, 12 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Doximity stock has an average upside potential 2026 of
28.67%
register free of charge
|
Mar '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 475.42 | 566.07 |
13.45% | 19.07% | |
EBITDA Margin | 38.50% | 54.52% |
16.75% | 41.62% | |
Net Margin | 28.41% | 33.29% |
19.74% | 17.19% |
19 Analysts have issued a sales forecast Doximity 2025 . The average Doximity sales estimate is
This results in the following potential growth metrics:
19 Analysts have issued an Doximity EBITDA forecast 2025. The average Doximity EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
13 Doximity Analysts have issued a net profit forecast 2025. The average Doximity net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Mar '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | 0.72 | 1.00 |
35.85% | 38.89% | |
P/E | 58.24 | |
EV/Sales | 17.92 |
13 Analysts have issued a Doximity forecast for earnings per share. The average Doximity EPS is
This results in the following potential growth metrics and future valuations:
Analyst | Rating | Action | Date |
---|---|---|---|
Goldman Sachs |
Locked
➜
Locked
|
Locked | Feb 10 2025 |
Mizuho |
Locked
➜
Locked
|
Locked | Feb 10 2025 |
Wells Fargo |
Locked
➜
Locked
|
Locked | Feb 07 2025 |
Leerink Partners |
Locked
➜
Locked
|
Locked | Feb 07 2025 |
Needham |
Locked
➜
Locked
|
Locked | Feb 07 2025 |
Raymond James |
Locked
➜
Locked
|
Locked | Feb 07 2025 |
Canaccord Genuity |
Locked
➜
Locked
|
Locked | Feb 07 2025 |
Analyst Rating | Date |
---|---|
Locked
Goldman Sachs:
Locked
➜
Locked
|
Feb 10 2025 |
Locked
Mizuho:
Locked
➜
Locked
|
Feb 10 2025 |
Locked
Wells Fargo:
Locked
➜
Locked
|
Feb 07 2025 |
Locked
Leerink Partners:
Locked
➜
Locked
|
Feb 07 2025 |
Locked
Needham:
Locked
➜
Locked
|
Feb 07 2025 |
Locked
Raymond James:
Locked
➜
Locked
|
Feb 07 2025 |
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Feb 07 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.